Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration.

Int J Mol Sci · 2022 · PMC9369115 · PMID 35955669

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, dissimilarly to AvnA, the RMSF profile of AvnC showed a trend superimposable to gefitinib, suggesting a similar activity on the target, in accordance with in vitro results.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.